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Lysyl oxidase activity in the culture medium of eight malignantly transformed human cell lines was very 
low compared with that in four control fibrobl~t lines, being 9-16s in five sarcoma celI lines and 7-l 1% 
in three other tumour cell lines. The low enzyme activity was probably due to deficient enzyme synthesis 
rather than impaired secretion into the cell medium, as low activity was also found in urea extracts of the 
cell pellets. Lysyl oxidase production thus appears to be closely regulated with deficient collagen gene ex- 
pression in malignant transformation. 
Lyryr oxidase Collagen 
1. INTRODUCTION 
Cells tr~sformed by tumour viruses or chemical 
carcinogens and spontaneous tumour cells all pro- 
duce greatly reduced amounts of fibronectin and 
collagen in culture, due to decreased copy numbers 
of the respective mRNAs (review [l]). This in turn 
is primarily caused by a reduced rate of transcrip- 
tion of the corresponding genes [2,3]. 
Collagen synthesis is characterized by the 
presence of an unusually large number of post- 
translational modifications, many of which are 
unique to collagens and a few other proteins 
(review [4]). These modifications require at least 8 
specific enzymes, 5 of them being intracellul~ and 
3 extracellular, as well as several non-specific en- 
zymes. Activities of the 5 intracellular enzymes 
have been studied previously in several transform- 
ed cell lines [S-7]. Prolyl 4-hydroxylase activity 
was low in the cell lines studied except in freshly 
transformed cells, whereas the 4 other enzyme ac- 
tivities showed a highly variable pattern, in that 
reduced, normal or even markedly high values 
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were found depending on the enzyme and the 
transformed cell type in question (5-71. The ex- 
tracellular conversion of procollagen to collagen 
has also been found to be impaired in at least some 
types of transformed fibroblasts, possibly due to a 
lack of procollagen proteinases [8-lo], whereas no 
data are available on the production of lysyl ox- 
idase by any transformed cells. 
Lysyl oxidase (EC 1.4.3.13) is an extracellular 
copper enzyme that initiates the cross-linking of 
collagens and elastin by catalyzing oxidative 
deamination of the e-amino group in certain lysine 
and hydroxylysine residues [ 111. A deficiency in 
this enzyme activity has recently been found in two 
human heritable connective tissue disorders 
characterized by abnormalities in copper metabo- 
lism [12-141. Changes in lysyl oxidase activity in 
the medium of cultured fibroblasts [12,15] and 
aortic smooth muscle cells [16] suggest hat the en- 
zyme may be regulated, as its activity varies, 
reaching its maximum at pre-confluency and being 
responsive to certain changes in the external en- 
vironment of the cells. Few data are available on 
such regulation, however. We now report very low 
levels of lysyl oxidase activity in a number of 
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human sarcoma and other tumour cell lines, sug- 
gesting that this enzyme activity may be closely 
regulated with collagen gene expression in malig- 
nant tr~sformation. 
2. MATERIALS AND METHODS 
The cultured human cell lines were locally 
established embryonal skin (HES) and lung (HEL) 
fibroblasts, commercially available foreskin 
fibroblasts (F-7000, Flow Laboratories, Irvine, 
Scotland), embryonal lung fibroblasts (WI-38, 
CCL 75 from the American Type Culture Collec- 
tion, Rockville, MD), SV40 virus-transformed 
WI-38 cells ~A-13/WI-38, CCL 75.1), fibrosar- 
coma cells (HT-1080, CCL 121), embryonal rhab- 
domyosarcoma cells (RD, CCL 136), trophoblastic 
choriocarcinoma cells (BeWo, CCL 98), another 
line of choriocarcinoma cells (JEG-3, HTB 36) and 
melanoma cells (G-361, CRL 1424), and also fur- 
ther adult rhabdomyosarcoma cells (A-204) and 
fibrosarcoma cells (8387) provided br( Drs J.E. 
DeLarco and G.J. Todaro (Frederick Cancer 
Research Center, Frederick, MD). The cells were 
grown in Eagle’s minimal essential medium sup- 
plemented with 10% foe&l calf serum, 100 
units/ml penicillin, 100 @g/ml streptomycin and 
50pglml ascorbate [5]. For the measurement of 
lysyl oxidase activity, subconfluent cells were 
washed twice with a solution of 0.01 M sodium 
phosphate and 0.14 M NaCl, pH 7.4, and then 
cultured for an additional 24 h period in the above 
medium without serum but supplemented with 
5 mg/ml bovine serum albumin [14,17]. This 
medium was collected and used for the assays of 
lysyl oxidase activity. In some experiments the cell 
pellets were prepared by trypsinization and the en- 
zyme activity was also measured in 4 M urea ex- 
tracts of the homogenized cell pellets [ 141. Special 
care was taken to avoid comparing density- 
inhibited control cells with over-growing trans- 
formed cells. 
Lysyl oxidase activity was assayed in a final 
volume of 0.6 ml with 0.8 x lo6 dpm [6-3H]lysine- 
labelled purified cock-embryo calvaria collagen as 
a substrate 114,181. The substrate was prein- 
cubated at 37OC for 60 min to promote fibril for- 
mation [18], and the incubation time with the en- 
zyme was then 10 h [14]. The cell culture media, 
which had been stored at -20°C for up to 3 
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weeks, were dialyzed for 3 h at 4OC against a solu- 
tion of 0.14 M NaCl in 0.1 M sodium phosphate, 
pH 7.8, and aliquots of the dialyzed media were 
then used for the assays without any prior concen- 
tration [14]. The urea extracts of the homogenized 
cell pellets were dialyzed for 8 h against the same 
solution. 
3. RESULTS AND DISCUSSION 
The 5 human sarcoma cell lines studied here 
(table 1) have previously been shown to produce 
collagen in reduced amounts as compared with 
several non-transformed human fibroblast lines 
(e.g. [5-71). The type of collagen synthesized 
varies, the SV40 virus-transformed WI-38 cells and 
the 8387 cells producing mainly type I collagen, the 
RD cells type III collagen, the HT-1080 cells type 
IV collagen, and the A-204 cells type V collagen 
[ 19,201. All the control cell lines synthesized main- 
ly type I collagen. 
Lysyl oxidase activity was markedly low in the 
medium of all 5 sarcoma cell lines (table 1). Signifi- 
cant differences were found even within the con- 
trol group in that the enzyme activity of the HES 
cells was significantly higher than of the WI-38 line 
(P < 0.05, &test) or the F-7000 cells (P < O.OOl), 
the difference between the latter two also being 
significant (P < 0.01). Nevertheless, such dif- 
ferences do not influence the main conclusion of 
markedly low lysyl oxidase activity in the sarcoma 
cells, as these values were in the range 9-16% of 
the control mean (table 1). The SV40 virus- 
transformed WI-38 cells had a lysyl oxidase activi- 
ty about 12% of that recorded in the corre- 
sponding non-transformed cell line WI-38. 
The 3 other malignant umour cell lines, BeWo, 
JEG-3 and G-361, likewise had very low lysyl ox- 
idase activity, about 7-11% of the control mean 
(table 1). As the activity values in all the sarcoma 
and other tumour cell lines are very low, being 
close to the borderline of detection, it cannot be 
determined whether any differences exist between 
the 2 groups of malignantly transformed cells in 
this respect. 
Prolyl 4-hydroxylase activity in the 5 sarcoma 
cell lines studied here is about 25-65% of that in 
a number of control fibroblast lines [5-71, the ac- 
tivity in the SV40 virus-transformed WI-38 cells 
being about 40% of that in the non-transformed 
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Table 1 
Lysyl oxidase activity in the medium of cultured cells 
Cell line na 
Control cells 
Embryonal skin fibroblasts (HES) 6 
Embryonal lung fibroblasts (HEL) 6 
Embryonal lung fibroblasts (WI-38) 6 
Foreskin fibroblasts (F-7000) 7 
Sarcoma cells - 
SV40 transformed WI-38 cells (Va 13/Wi-38) 3 
Fibrosarcoma cells (8387) 8 
Fibrosarcoma cells (HT-1080) 6 
Embryonal rhabdomyosarcoma cells (RD) 8 
Adult rhabdomyosarcoma cells (A-204) 8 
Other transformed cells 
Choriocarcinoma cells (BeWo) 5 
Choriocarcinoma cells (JEG-3) 8 
Melanoma cells (G-361) 7 
a Number of independent measurements on separate cell cultures 
Lysyl oxidase activity 
dpm/106 cells % of control mean 
4150 f 790 
2950 f 1180 
3080 f 580 
2260 f 320 
380 f 10 12.2 
280 f 100 9.0 
490 f 180 15.8 
390* 200 12.5 
280 f 120 9.0 
210 f 140 6.8 
310 + 120 10.0 
330 f 230 10.6 
b Mean + SD 
WI-38 cells [5]. The activities of the 4 other specific 
intracellular enzymes of collagen synthesis vary 
from about 50 to 220% of the control values, part 
of this variation probably reflecting differences in 
the types of collagen synthesized [5-71. The pre- 
sent data indicate that lysyl oxidase activity is 
reduced in malignantly transformed cells to a 
much greater degree than that of any of the 
specific intracellular enzyme activities. 
About 90% of the lysyl oxidase activity in 
fibroblast cultures is usually found in the medium, 
an additional 10% being extractable from the cell 
pellets with 4 M urea [14]. To study whether the 
low enzyme activity in the malignantly trans- 
formed cells is due to deficient secretion of the en- 
zyme, lysyl oxidase activity was also measured in 
such urea extracts. No accumulation of the enzyme 
was found in the cell pellets, however, the value in 
the transformed cells being even lower than in the 
controls and falling below the limit of accurate 
assay. It therefore seems that the deficient lysyl ox- 
idase production in malignantly transformed cells 
is due to a low rate of enzyme synthesis, possibly 
caused by decreased transcription of the cor- 
responding gene(s), a mechanism that has been 
demonstrated for transformed cells in the case of 
low collagen production [2,3]. The present data in- 
dicate an efficient regulation of lysyl oxidase ac- 
tivity with the rate of collagen synthesis in malig- 
nant transformation. Further work is needed to 
demonstrate whether a more general phenomenon 
of coordinated regulation between the lysyl ox- 
idase and collagen production exists. 
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